References
Tan YuPing, Yang B, Chen YuHong et al (2023) Outcomes of metaplastic breast cancer versus triple-negative breast cancer: a propensity score matching analysis. World J Surg. https://doi.org/10.1007/s00268-023-07106-1
Luini A, Aguilar M, Gatti G et al (2007) Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European institute of oncology and review of the literature. Breast Cancer Res Treat 101(3):349–353 ([PubMed: 17009109])
El Zein D, Hughes M, Kumar S et al (2017) Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a study from a single institution and review of literature. Clin Breast Cancer 17(5):382–391. https://doi.org/10.1016/j.clbc.2017.04.009
Lester TR, Hunt KK, Nayeemuddin KM et al (2012) Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers. Breast Cancer Res Treat 131:41–48 ([PubMed: 21331622])
Agarwal G, Vishvak Chanthar KMM, Katiyar S et al (2023) Predictive and prognostic role of tumor-infiltrating lymphocytes in patients with advanced breast cancer treated with primary systemic therapy. World J Surg 47(5):1238–1246. https://doi.org/10.1007/s00268-023-06912-x. (Epub 2023 Feb 3 PMID: 36735048)
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Agarwal, G., Chanthar, K.M.M.V. Commentary: Outcomes of Metaplastic Breast Cancer vs. Triple-Negative Breast Cancer. World J Surg 47, 3203–3204 (2023). https://doi.org/10.1007/s00268-023-07187-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-023-07187-y